FcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity

Neutrophils are versatile immune cells that may also serve as antigen-presenting cells (APC). Here the authors show that engaging FcγRs on neutrophils with immune complexes or an anti-FcγR-antigen conjugate induces neutrophil APC with comparable functions as classical dendritic cells, and with thera...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vijayashree Mysore, Xavier Cullere, Joseph Mears, Florencia Rosetti, Koshu Okubo, Pei X. Liew, Fan Zhang, Iris Madera-Salcedo, Frank Rosenbauer, Richard M. Stone, Jon C. Aster, Ulrich H. von Andrian, Andrew H. Lichtman, Soumya Raychaudhuri, Tanya N. Mayadas
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/86a5a1c6c18f436081a1927c18c8de2d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:86a5a1c6c18f436081a1927c18c8de2d
record_format dspace
spelling oai:doaj.org-article:86a5a1c6c18f436081a1927c18c8de2d2021-12-02T15:07:49ZFcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity10.1038/s41467-021-24591-x2041-1723https://doaj.org/article/86a5a1c6c18f436081a1927c18c8de2d2021-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-24591-xhttps://doaj.org/toc/2041-1723Neutrophils are versatile immune cells that may also serve as antigen-presenting cells (APC). Here the authors show that engaging FcγRs on neutrophils with immune complexes or an anti-FcγR-antigen conjugate induces neutrophil APC with comparable functions as classical dendritic cells, and with therapeutic potentials for cancer and infectious diseases.Vijayashree MysoreXavier CullereJoseph MearsFlorencia RosettiKoshu OkuboPei X. LiewFan ZhangIris Madera-SalcedoFrank RosenbauerRichard M. StoneJon C. AsterUlrich H. von AndrianAndrew H. LichtmanSoumya RaychaudhuriTanya N. MayadasNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-23 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Vijayashree Mysore
Xavier Cullere
Joseph Mears
Florencia Rosetti
Koshu Okubo
Pei X. Liew
Fan Zhang
Iris Madera-Salcedo
Frank Rosenbauer
Richard M. Stone
Jon C. Aster
Ulrich H. von Andrian
Andrew H. Lichtman
Soumya Raychaudhuri
Tanya N. Mayadas
FcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity
description Neutrophils are versatile immune cells that may also serve as antigen-presenting cells (APC). Here the authors show that engaging FcγRs on neutrophils with immune complexes or an anti-FcγR-antigen conjugate induces neutrophil APC with comparable functions as classical dendritic cells, and with therapeutic potentials for cancer and infectious diseases.
format article
author Vijayashree Mysore
Xavier Cullere
Joseph Mears
Florencia Rosetti
Koshu Okubo
Pei X. Liew
Fan Zhang
Iris Madera-Salcedo
Frank Rosenbauer
Richard M. Stone
Jon C. Aster
Ulrich H. von Andrian
Andrew H. Lichtman
Soumya Raychaudhuri
Tanya N. Mayadas
author_facet Vijayashree Mysore
Xavier Cullere
Joseph Mears
Florencia Rosetti
Koshu Okubo
Pei X. Liew
Fan Zhang
Iris Madera-Salcedo
Frank Rosenbauer
Richard M. Stone
Jon C. Aster
Ulrich H. von Andrian
Andrew H. Lichtman
Soumya Raychaudhuri
Tanya N. Mayadas
author_sort Vijayashree Mysore
title FcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity
title_short FcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity
title_full FcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity
title_fullStr FcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity
title_full_unstemmed FcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity
title_sort fcγr engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/86a5a1c6c18f436081a1927c18c8de2d
work_keys_str_mv AT vijayashreemysore fcgrengagementreprogramsneutrophilsintoantigencrosspresentingcellsthatelicitacquiredantitumorimmunity
AT xaviercullere fcgrengagementreprogramsneutrophilsintoantigencrosspresentingcellsthatelicitacquiredantitumorimmunity
AT josephmears fcgrengagementreprogramsneutrophilsintoantigencrosspresentingcellsthatelicitacquiredantitumorimmunity
AT florenciarosetti fcgrengagementreprogramsneutrophilsintoantigencrosspresentingcellsthatelicitacquiredantitumorimmunity
AT koshuokubo fcgrengagementreprogramsneutrophilsintoantigencrosspresentingcellsthatelicitacquiredantitumorimmunity
AT peixliew fcgrengagementreprogramsneutrophilsintoantigencrosspresentingcellsthatelicitacquiredantitumorimmunity
AT fanzhang fcgrengagementreprogramsneutrophilsintoantigencrosspresentingcellsthatelicitacquiredantitumorimmunity
AT irismaderasalcedo fcgrengagementreprogramsneutrophilsintoantigencrosspresentingcellsthatelicitacquiredantitumorimmunity
AT frankrosenbauer fcgrengagementreprogramsneutrophilsintoantigencrosspresentingcellsthatelicitacquiredantitumorimmunity
AT richardmstone fcgrengagementreprogramsneutrophilsintoantigencrosspresentingcellsthatelicitacquiredantitumorimmunity
AT joncaster fcgrengagementreprogramsneutrophilsintoantigencrosspresentingcellsthatelicitacquiredantitumorimmunity
AT ulrichhvonandrian fcgrengagementreprogramsneutrophilsintoantigencrosspresentingcellsthatelicitacquiredantitumorimmunity
AT andrewhlichtman fcgrengagementreprogramsneutrophilsintoantigencrosspresentingcellsthatelicitacquiredantitumorimmunity
AT soumyaraychaudhuri fcgrengagementreprogramsneutrophilsintoantigencrosspresentingcellsthatelicitacquiredantitumorimmunity
AT tanyanmayadas fcgrengagementreprogramsneutrophilsintoantigencrosspresentingcellsthatelicitacquiredantitumorimmunity
_version_ 1718388400793321472